文献速递哮喘慢阻肺

基于呼气分析技术的慢性气道疾病临床与炎症表型分型:不依赖诊断标签

Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
PubMed 文献 · Eur Respir J · 2018-01-11

该多中心横断面研究纳入435例哮喘和慢阻肺患者,使用电子鼻分析呼出气,通过主成分分析和聚类分析识别出5个不依赖诊断标签的临床/炎症表型集群,并在验证集中得到验证。电子鼻可剂量依赖性地识别全身性中性粒细胞增多和/或嗜酸性粒细胞增多。

要点

  • 电子鼻呼出气分析可识别哮喘和慢阻肺患者中不依赖诊断的临床/炎症表型集群。
  • 电子鼻可预测血嗜酸性粒细胞和中性粒细胞计数,回归模型R²分别为0.581和0.409。
  • 聚类结果在验证集中得到重复,支持呼气分析用于炎症表型分型的潜力。

核心结论

  • 基于电子鼻的呼出气分析可在哮喘和慢阻肺混合人群中识别出不由诊断决定、而由临床/炎症特征决定的表型集群,并在验证集中得到验证。

研究设计与样本

  • 多中心横断面研究,纳入哮喘和慢阻肺患者共435例(训练集321例,验证集114例),使用电子鼻技术分析呼出气。

主要发现

  • 基于电子鼻的聚类分析得到5个显著的哮喘和慢阻肺联合集群,集群间在种族(p=0.01)、全身性嗜酸性粒细胞增多(p=0.02)、中性粒细胞增多(p=0.03)、体重指数(p=0.04)、呼出气一氧化氮分数(p<0.01)、特应性(p<0.01)和急性加重率(p<0.01)方面存在差异。
  • 基于电子鼻预测嗜酸性粒细胞(R²=0.581)和中性粒细胞(R²=0.409)血计数的回归模型显著。
  • 验证集中获得了相似的集群和回归结果。
  • 电子鼻以剂量依赖方式识别全身性中性粒细胞增多和/或嗜酸性粒细胞增多。

临床怎么用

  • 电子鼻呼气分析有望作为快速、无创的工具,用于慢性气道疾病患者的炎症表型分型,指导抗嗜酸性粒细胞/抗中性粒细胞治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Asthma and chronic obstructive pulmonary disease (COPD) are complex and overlapping diseases that include inflammatory phenotypes. Novel anti-eosinophilic/anti-neutrophilic strategies demand rapid inflammatory phenotyping, which might be accessible from exhaled breath.Our objective was to capture clinical/inflammatory phenotypes in patients with chronic airway disease using an electronic nose (eNose) in a training and validation set.This was a multicentre cross-sectional study in which exhaled breath from asthma and COPD patients (n=435; training n=321 and validation n=114) was analysed using eNose technology. Data analysis involved signal processing and statistics based on principal component analysis followed by unsupervised cluster analysis and supervised linear regression.Clustering based on eNose resulted in five significant combined asthma and COPD clusters that differed regarding ethnicity (p=0.01), systemic eosinophilia (p=0.02) and neutrophilia (p=0.03), body mass index (p=0.04), exhaled nitric oxide fraction (p<0.01), atopy (p<0.01) and exacerbation rate (p<0.01). Significant regression models were found for the prediction of eosinophilic (R2=0.581) and neutrophilic (R2=0.409) blood counts based on eNose. Similar clusters and regression results were obtained in the validation set.Phenotyping a combined sample of asthma and COPD patients using eNose provides validated clusters that are not determined by diagnosis, but rather by clinical/inflammatory characteristics. eNose identified systemic neutrophilia and/or eosinophilia in a dose-dependent manner.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. de Vries R, Dagelet YWF, Spoor P, et al. Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label. Eur Respir J. 2018. PMID: 29326334. doi:10.1183/13993003.01817-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。